Stephen T Higgins1, Yukiko Washio2, Alexa A Lopez3, Sarah H Heil3, Laura J Solomon4, Mary Ellen Lynch5, Jennifer D Hanson2, Tara M Higgins2, Joan M Skelly6, Ryan Redner5, Ira M Bernstein7. 1. Vermont Center on Behavior and Health, University of Vermont, USA; Department of Psychiatry, University of Vermont, USA; Department of Psychology, University of Vermont, USA. Electronic address: Stephen.Higgins@uvm.edu. 2. Department of Psychiatry, University of Vermont, USA. 3. Vermont Center on Behavior and Health, University of Vermont, USA; Department of Psychiatry, University of Vermont, USA; Department of Psychology, University of Vermont, USA. 4. Department of Family Practice, University of Vermont, USA. 5. Vermont Center on Behavior and Health, University of Vermont, USA; Department of Psychiatry, University of Vermont, USA. 6. Department of Medical Biostatistics, University of Vermont, USA. 7. Vermont Center on Behavior and Health, University of Vermont, USA; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Vermont, USA.
Abstract
OBJECTIVE: To examine whether an efficacious voucher-based incentives intervention for decreasing smoking during pregnancy and increasing fetal growth could be improved without increasing costs. The strategy was to redistribute the usual incentives so that higher values were available early in the quit attempt. METHOD:118 pregnant smokers in greater Burlington, Vermont (studied December, 2006-June, 2012) were randomly assigned to the revised contingent voucher (RCV) or usual contingent voucher (CV) schedule of abstinence-contingent vouchers, or to a non-contingent voucher (NCV) control condition wherein vouchers were provided independent of smoking status. Smoking status was biochemically verified; serial sonographic estimates of fetal growth were obtained at gestational weeks 30-34. RESULTS:RCV and CV conditions increased point-prevalence abstinence above NCV levels at early (RCV: 40%, CV: 46%, NCV: 13%, p=.007) and late-pregnancy (RCV: 45%; CV: 36%; NCV, 18%; p=.04) assessments, but abstinence levels did not differ between the RCV and CV conditions. The RCV intervention did not increase fetal growth above control levels while the CV condition did so (p<.05). CONCLUSION: This trial further supports the efficacy of CV for increasing antepartum abstinence and fetal growth, but other strategies (e.g., increasing overall incentive values) will be necessary to improve outcomes further.
RCT Entities:
OBJECTIVE: To examine whether an efficacious voucher-based incentives intervention for decreasing smoking during pregnancy and increasing fetal growth could be improved without increasing costs. The strategy was to redistribute the usual incentives so that higher values were available early in the quit attempt. METHOD: 118 pregnant smokers in greater Burlington, Vermont (studied December, 2006-June, 2012) were randomly assigned to the revised contingent voucher (RCV) or usual contingent voucher (CV) schedule of abstinence-contingent vouchers, or to a non-contingent voucher (NCV) control condition wherein vouchers were provided independent of smoking status. Smoking status was biochemically verified; serial sonographic estimates of fetal growth were obtained at gestational weeks 30-34. RESULTS: RCV and CV conditions increased point-prevalence abstinence above NCV levels at early (RCV: 40%, CV: 46%, NCV: 13%, p=.007) and late-pregnancy (RCV: 45%; CV: 36%; NCV, 18%; p=.04) assessments, but abstinence levels did not differ between the RCV and CV conditions. The RCV intervention did not increase fetal growth above control levels while the CV condition did so (p<.05). CONCLUSION: This trial further supports the efficacy of CV for increasing antepartum abstinence and fetal growth, but other strategies (e.g., increasing overall incentive values) will be necessary to improve outcomes further.
Authors: R A Windsor; J B Lowe; L L Perkins; D Smith-Yoder; L Artz; M Crawford; K Amburgy; N R Boyd Journal: Am J Public Health Date: 1993-02 Impact factor: 9.308
Authors: Stephen T Higgins; Sarah H Heil; Laura J Solomon; Ira M Bernstein; Jennifer Plebani Lussier; Rebecca L Abel; Mary Ellen Lynch; Gary J Badger Journal: Nicotine Tob Res Date: 2004-12 Impact factor: 4.244
Authors: Stephen T Higgins; Yukiko Washio; Sarah H Heil; Laura J Solomon; Diann E Gaalema; Tara M Higgins; Ira M Bernstein Journal: Prev Med Date: 2011-12-27 Impact factor: 4.018
Authors: R A Windsor; G Cutter; J Morris; Y Reese; B Manzella; E E Bartlett; C Samuelson; D Spanos Journal: Am J Public Health Date: 1985-12 Impact factor: 9.308
Authors: Taraneh Taghavi; Christopher A Arger; Sarah H Heil; Stephen T Higgins; Rachel F Tyndale Journal: Addiction Date: 2018-07-23 Impact factor: 6.526
Authors: Sarah M Wilson; Amie R Newins; Alyssa M Medenblik; Nathan A Kimbrel; Eric A Dedert; Terrell A Hicks; Lydia C Neal; Jean C Beckham; Patrick S Calhoun Journal: Womens Health Issues Date: 2018-07-27